There has been alot in the press recently regarding the use of Mounjaro, a weekly injection that is prescribed alongside a reduced calorie diet and exercise.. Mounjaro is a glucoagon - like peptide-1 (GLP -1) agonist. The NHS plan to roll this out from March 2025 to patients who are obese with weight related health problems. The patient must have a body mass index of 30kg/m or 27-30 kg/m with at least one weight related health problem, such as:
Prediabetes
High blood pressure
Heart cholesteraol
Heart problems
Type 2 diabetes.
The roll out of Mounjaro in the NHS could take up to 12 years.
At our CQC York Clinic we offer the weightloss programme giving our patients a high standard of care, support using only reputable UK suppliers, sourced directly from the authorised pharmacy. Nurse Lee regularly is in contact with the Mounajo Representative ensuring she had access to all clincal trial and papers ensuring a safef service.
